Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 0.00% is 100% above its 5-year average of -1679.75%, near the high end of its 5-year range (-16953.46%–0.00%).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
-1679.75%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
+100.00%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 598 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Gain Therapeutics, Inc.
Market Cap
$72.73M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-1679.75%
Market Cap
$71.66M
Operating Margin
-96.01%
TTM Avg
-72.88%
3Y Avg
-81.45%
5Y Avg
-72.54%
Market Cap
$69.26M
Operating Margin
-1.72%
TTM Avg
3.29%
3Y Avg
-3.87%
5Y Avg
-2.22%
Market Cap
$77.28M
Operating Margin
-145459.36%
TTM Avg
-145459.36%
3Y Avg
-145459.36%
5Y Avg
-145459.36%
Market Cap
$68.81M
Operating Margin
-35141.00%
TTM Avg
-19895.75%
3Y Avg
-11796.10%
5Y Avg
-8345.47%
Market Cap
$77.55M
Operating Margin
-273.43%
TTM Avg
-304.38%
3Y Avg
-532.26%
5Y Avg
-2409.22%
Market Cap
$68.07M
Operating Margin
-111.00%
TTM Avg
-151.19%
3Y Avg
-184.89%
5Y Avg
-203.40%
Market Cap
$78.76M
Operating Margin
-132871.32%
TTM Avg
-92244.12%
3Y Avg
-51098.97%
5Y Avg
-37173.74%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Gain Therapeutics, Inc. (GANX) | $72.73M | 0.00% | 0.00% | 0.00% | -1679.75% |
| MindWalk Holdings Corp. (HYFT)vs › | $71.66M | -96.01% | -72.88% | -81.45% | -72.54% |
| Champions Oncology, Inc. (CSBR)vs › | $69.26M | -1.72% | 3.29% | -3.87% | -2.22% |
| Neonc Technologies Holdings, Inc. (NTHI)vs › | $77.28M | -145459.36% | -145459.36% | -145459.36% | -145459.36% |
| iBio, Inc. (IBIO)vs › | $68.81M | -35141.00% | -19895.75% | -11796.10% | -8345.47% |
| Hyperfine, Inc. (HYPR)vs › | $77.55M | -273.43% | -304.38% | -532.26% | -2409.22% |
| Fortress Biotech, Inc. (FBIO)vs › | $68.07M | -111.00% | -151.19% | -184.89% | -203.40% |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $78.76M | -132871.32% | -92244.12% | -51098.97% | -37173.74% |
| Cingulate Inc. (CING)vs › | $66.18M | 0.00% | 0.00% | 0.00% | 0.00% |
| Pulmonx Corporation (LUNG)vs › | $79.62M | -52.96% | -64.09% | -81.91% | -87.35% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | -9477.68% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | -5442.98% |
| 2022-03-31 | -7306.75% |
| 2021-12-31 | -7426.33% |
| 2021-09-30 | -16953.46% |
| 2021-06-30 | -3941.29% |
| 2021-03-31 | -46819.42% |
| 2020-12-31 | -17678.47% |
| 2020-09-30 | -12232.51% |
| 2020-06-30 | -8355.01% |
| 2020-03-31 | -7676.61% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | -5085.01% |
| 2019-06-30 | -5085.01% |
| 2019-03-31 | -5085.01% |
| 2018-09-30 | -4989.90% |
| 2018-06-30 | -4989.90% |
| 2018-03-31 | -4989.90% |
